Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. [electronic resource]
Producer: 20050321Description: 701-6 p. digitalISSN:- 1087-0156
- Animals
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- chemistry
- Benzoquinones
- Blotting, Western
- Cell Line, Tumor
- Copper Radioisotopes
- Female
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Heterocyclic Compounds, 1-Ring -- chemistry
- Humans
- Immunoblotting
- Immunoglobulin Fab Fragments -- chemistry
- Indium Radioisotopes
- Isotope Labeling
- Lactams, Macrocyclic
- Mice
- Mice, Nude
- Molecular Probe Techniques
- Neoplasms -- chemistry
- Phosphatidylinositol 3-Kinases -- metabolism
- Positron-Emission Tomography -- methods
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Receptor, ErbB-2 -- drug effects
- Rifabutin -- analogs & derivatives
- Tissue Distribution
- Trastuzumab
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.